Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Oncolytics Biotech Inc (ONCY)

Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Breakthroughs Spearhead Fight Against Rising Breast Cancer Cases BayStreet.ca - Thu Apr 11, 8:49AM CDT

USA News Group – The American Cancer Society is projecting 2024 to be the first year ever for the US to have more than 2 million new cases, which would represent a record high. Among 10 of the most common...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
GILD : 66.76 (+0.91%)
GTHX : 4.11 (-1.44%)
AZN : 68.55 (+0.28%)
HOLX : 75.38 (+0.37%)
Biotech Innovations Paving the Way in Breast Cancer Fight FinancialNewsMedia - Thu Apr 11, 8:15AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
GILD : 66.76 (+0.91%)
GTHX : 4.11 (-1.44%)
AZN : 68.55 (+0.28%)
HOLX : 75.38 (+0.37%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA FinancialNewsMedia - Thu Apr 11, 7:27AM CDT

Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metastatic breast cancer Overall survival results from the randomized HR+/HER2- metastatic breast...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Newswire.ca - Thu Apr 11, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapeutics for oncology, is pleased to...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
Oncolytics Biotech® to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference Newswire.ca - Tue Apr 2, 6:00AM CDT

/CNW/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on oncology, today announced that President...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
Biotech Sector Advances in Pancreatic Cancer Research BayStreet.ca - Thu Mar 14, 8:42AM CDT

USA News Group – Known as one of the most deadly forms of cancer, pancreatic cancer still has the highest mortality rate of all major cancers today. However, researchers and the biotech sector are working...

BRX : 21.47 (+0.75%)
ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
NVS : 94.36 (+1.93%)
IBRX : 5.27 (+7.33%)
ACRS : 1.2400 (+0.81%)
NUVB : 2.60 (+0.78%)
Biotech’s Role in Addressing the Pancreatic Cancer Emergency FinancialNewsMedia - Thu Mar 14, 7:45AM CDT

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVX),(NASDAQ:IBRX),(NASDAQ:ACRS),(NYSE:NUVB) EQNX::TICKER_END

NVX : 2.30 (-2.58%)
ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
NVS : 94.36 (+1.93%)
IBRX : 5.27 (+7.33%)
ACRS : 1.2400 (+0.81%)
NUVB : 2.60 (+0.78%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth FinancialNewsMedia - Wed Mar 6, 7:40AM CST

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
BLRX : 0.6565 (+2.56%)
IMRX : 1.8000 (+1.69%)
CADL : 5.17 (-5.31%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning Newsfile - Wed Mar 6, 7:06AM CST

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - March 6, 2024) - Investorideas.com, a global investor news source covering biotech and pharma stocks issues a sector snapshot on developments...

ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments FinancialNewsMedia - Tue Mar 5, 7:30AM CST

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:OCEA),(NASDAQ:LVTX),(NYSE:MRK),(NYSE:ABBV) EQNX::TICKER_END

OCEA : 1.7600 (-6.13%)
ONCY : 1.0600 (+2.91%)
ONC.TO : 1.44 (+0.70%)
LVTX : 2.71 (-4.24%)
MRK : 125.78 (+0.44%)
ABBV : 166.41 (+1.06%)

Barchart Exclusives

Dividend Newcomers: Discover 3 Companies Starting To Share the Wealth Barchart - 49 minutes ago
Discover the potential of newly initiated dividends—start building your wealth with tomorrow's top dividend payers today! Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot